Your browser doesn't support javascript.
loading
Hyperuricemia contributes to glucose intolerance of hepatic inflammatory macrophages and impairs the insulin signaling pathway via IRS2-proteasome degradation.
Zhao, Hairong; Lu, Jiaming; He, Furong; Wang, Mei; Yan, Yunbo; Chen, Binyang; Xie, De; Xu, Chenxi; Wang, Qiang; Liu, Weidong; Yu, Wei; Xi, Yuemei; Yu, Linqian; Yamamoto, Tetsuya; Koyama, Hidenori; Wang, Wei; Zhang, Chenggui; Cheng, Jidong.
Afiliação
  • Zhao H; Department of Endocrinology, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, China.
  • Lu J; Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical Research and Development (R&D), College of Pharmacy, Dali University, Dali, China.
  • He F; Department of Endocrinology, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, China.
  • Wang M; Department of Endocrinology, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, China.
  • Yan Y; Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical Research and Development (R&D), College of Pharmacy, Dali University, Dali, China.
  • Chen B; Department of Endocrinology, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, China.
  • Xie; Department of Endocrinology, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, China.
  • Xu C; Department of Endocrinology, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, China.
  • Wang Q; Department of Endocrinology, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, China.
  • Liu W; Department of Endocrinology, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, China.
  • Yu W; Department of Endocrinology, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, China.
  • Xi Y; Department of Endocrinology, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, China.
  • Yu L; Department of Endocrinology, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, China.
  • Yamamoto T; Department of Endocrinology, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, China.
  • Koyama H; Department of Diabetes, Endocrinology and Clinical Immunology, Hyogo College of Medicine, Nishinomiya, Japan.
  • Wang W; Department of Diabetes, Endocrinology and Clinical Immunology, Hyogo College of Medicine, Nishinomiya, Japan.
  • Zhang C; Department of Endocrinology, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, China.
  • Cheng J; Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical Research and Development (R&D), College of Pharmacy, Dali University, Dali, China.
Front Immunol ; 13: 931087, 2022.
Article em En | MEDLINE | ID: mdl-36177037

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Intolerância à Glucose / Hiperuricemia / Diabetes Mellitus Tipo 2 Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Intolerância à Glucose / Hiperuricemia / Diabetes Mellitus Tipo 2 Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article